Literature DB >> 12538432

Skeletal muscle reflex in heart failure patients: role of hydrogen.

Adam C Scott1, Roland Wensel, Constantinos H Davos, Panagiota Georgiadou, Michael Kemp, James Hooper, Andrew J S Coats, Massimo F Piepoli.   

Abstract

BACKGROUND: An important role of the increased stimulation of skeletal muscle ergoreceptors (intramuscular afferents sensitive to products of muscle work) in the genesis of symptoms of exertion intolerance in chronic heart failure (CHF) has been proposed. With the use of selective infusions and dietary manipulation methods, we sought to identify the role of H+, K+, lactate, and peripheral hemodynamics on ergoreflex overactivation. METHODS AND
RESULTS: Ten stable CHF patients (aged 67.9+/-2.5 years, peak oxygen uptake 16.3+/-1.2 mL x kg(-1) x min(-1)) and 10 age-matched and sex-matched healthy subjects were studied. The ergoreflex contribution to ventilation was assessed by post-handgrip regional circulatory occlusion (PH-RCO) and computed as the difference in ventilation between PH-RCO and a control run without PH-RCO. This test was performed on 6 separate occasions. On each occasion a different chemical was infused (insulin, sodium nitroprusside, sodium bicarbonate, dopamine, or saline) or a 36-hour glucose-free diet was undertaken before the test. During all stages of the protocol, the local muscular blood effluent concentrations of H+, K+, glucose, and lactate were assessed. An ergoreflex effect on the ventilatory response was seen in patients (versus control subjects) during the saline infusions (6.7+/-2.3 L/min versus -0.1+/-0.5 L/min, P<0.01). The only intervention to significantly lower the ergoreflex was sodium bicarbonate (0.4+/-0.3 L/min versus -0.2+/-0.4 L/min in control subjects, P=NS; versus saline P<0.05), which also reduced H(+) concentration during exercise (47.4+/-1.3 versus 50.0+/-1.4 nmol/L on saline, P<0.05).
CONCLUSION: A reduction of the H+ concentration by infusion of sodium bicarbonate abolishes the increased ergoreceptor activity in CHF, suggesting a role of H+ in ergoreflex activation, either directly or indirectly.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12538432     DOI: 10.1161/01.cir.0000042704.37387.29

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  22 in total

1.  Heart failure induces changes in acid-sensing ion channels in sensory neurons innervating skeletal muscle.

Authors:  David D Gibbons; William J Kutschke; Robert M Weiss; Christopher J Benson
Journal:  J Physiol       Date:  2015-09-23       Impact factor: 5.182

Review 2.  Abnormalities in cardiopulmonary exercise testing ventilatory parameters in heart failure: pathophysiology and clinical usefulness.

Authors:  Marco Guazzi
Journal:  Curr Heart Fail Rep       Date:  2014-03

Review 3.  Exercise training in heart failure.

Authors:  Massimo F Piepoli
Journal:  Curr Heart Fail Rep       Date:  2006-04

Review 4.  Cardioprotection by remote ischemic conditioning: Mechanisms and clinical evidences.

Authors:  Alberto Aimo; Chiara Borrelli; Alberto Giannoni; Luigi Emilio Pastormerlo; Andrea Barison; Gianluca Mirizzi; Michele Emdin; Claudio Passino
Journal:  World J Cardiol       Date:  2015-10-26

Review 5.  Skeletal muscle abnormalities in chronic heart failure.

Authors:  Panagiota Georgiadou; Stamatis Adamopoulos
Journal:  Curr Heart Fail Rep       Date:  2012-06

6.  Impact of Non-Invasive Ventilation on Sympathetic Nerve Activity in Chronic Obstructive Pulmonary Disease.

Authors:  Helge Haarmann; Jan Folle; Xuan Phuc Nguyen; Peter Herrmann; Karsten Heusser; Gerd Hasenfuß; Stefan Andreas; Tobias Raupach
Journal:  Lung       Date:  2016-11-16       Impact factor: 2.584

7.  Exercise training in heart failure.

Authors:  Massimo F Piepoli
Journal:  Curr Heart Fail Rep       Date:  2006-12

Review 8.  Exercise training in heart failure.

Authors:  Massimo F Piepoli
Journal:  Curr Cardiol Rep       Date:  2005-05       Impact factor: 2.931

9.  V̇o2 kinetics associated with moderate-intensity exercise in heart failure: impact of intrathecal fentanyl inhibition of group III/IV locomotor muscle afferents.

Authors:  Erik H Van Iterson; Bruce D Johnson; Michael J Joyner; Timothy B Curry; Thomas P Olson
Journal:  Am J Physiol Heart Circ Physiol       Date:  2017-05-05       Impact factor: 4.733

10.  Prolylcarboxypeptidase (PRCP) as a new target for obesity treatment.

Authors:  B Shariat-Madar; D Kolte; A Verlangieri; Z Shariat-Madar
Journal:  Diabetes Metab Syndr Obes       Date:  2010-04       Impact factor: 3.168

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.